### **1. Company Overview** Control Print Limited, founded in 1991 and headquartered in Mumbai, is India’s leading domestic manufacturer of coding and marking solutions and the only Indian player among the top four organized players in this sector. The company is a flagship “Make in India” success story, operating full end-to-end integrated manufacturing of printers, consumables, software, and services from its facilities in Nalagarh (Himachal Pradesh) and Guwahati (Assam). With over three decades of operational experience, Control Print has evolved from a distributor of foreign brands to a technology-driven innovator in industrial printing, packaging, and digital traceability. As of November 2025, Control Print is focused on strategic transformation, targeting **global expansion**, **technology diversification**, and **adjacent growth** beyond its core coding and marking business. --- ### **2. Core Business: Coding & Marking** Control Print is a dominant player in the organized Indian coding and marking market, valued at **₹2,000–2,200 crore**. The sector is highly consolidated, with four players controlling ~80% of the market. Control Print holds an **18–20% market share** of the organized segment and is the only Indian-owned company in this elite group. #### **Key Financials (Standalone India Business):** - **Revenue (FY24–25):** ₹385 crore - **Growth:** Outpacing industry average (industry growing at ~1.5x GDP) - **Profitability Driver:** CIJ (Continuous Inkjet) division remains the core, but TTO, TIJ, Laser, and HiRes printers are showing rapid growth. #### **Product Portfolio:** - **Technologies Offered:** CIJ, TTO, TIJ, Laser (Fiber), Hot Roll Coders, LCP, and high-resolution piezo inkjet printers. - **Markets Served:** Industrial (65%) and Packaging (35%), with major verticals including: - Dairy, FMCG, Pharmaceuticals, Steel, Cement, Pipes & Cables, Food & Beverages, Chemicals - **Installed Base:** Over **21,500 printers** across **1,700+ cities** and **2,700+ pin codes** in India - **Service Network:** 350+ field engineers ensuring uptime and customer retention #### **Revenue Model:** - **Recurring Revenue Focus:** 60–65% of revenue comes from consumables (inks, solvents), enabling high-margin, sticky income over the 8–15-year printer lifecycle. - **After-Sales:** Service, spares, maintenance contracts (AMCs), and training generate consistent revenue. --- ### **3. Strategic Growth Pillars** Control Print is actively pursuing exponential growth through three parallel strategies: **international expansion**, **technology innovation**, and **diversification** into new, high-potential verticals. #### **A. Global Expansion & Subsidiaries** To overcome domestic market size limitations, Control Print has executed a bold international strategy through acquisitions and expansion: | **Subsidiary** | **Ownership** | **Location** | **Focus** | |---------------|--------------|--------------|--------| | **Markprint BV** | 85% | Netherlands | High-speed digital printing, print-and-apply systems | | **Codeology Group Ltd** | 50.49% | UK | Label print-and-apply, end-of-line automation, conveyor integration | | **CP Italy S.r.l. (V-Shapes)** | 100% | Italy | Single-serve packaging machinery & materials | | **Control Print MEA FZE** | 100% | UAE | Regional hub for Middle East & Africa (MEA) | - **Strategy:** Leverage global subsidiaries to access new technology, markets, and revenue streams while introducing these products into India. - **Progress:** Initial success in securing key orders in the Middle East and Europe. Business plans for overseas subsidiaries are finalized and being operationally executed. #### **B. Track & Trace – QRiousCodes** An in-house, cloud-based **Track and Trace (T&T) platform** designed for regulatory compliance and supply chain transformation. - **Platform:** **QRiousCodes** – Uses blockchain-based Unique Identifiers (UIDs), cloud software, and proprietary hybrid technology for: - Serialization of pharmaceuticals (government mandate for top 1,000 drugs) - Anti-counterfeiting - Real-time supply chain visibility - Consumer engagement via scannable QR codes - **End-to-End Solution:** Includes hardware (printers), vision systems, software, ERP integration, and data analytics. - **Key Markets:** Pharma, agrochemicals, cosmetics, food - **Revenue Model:** Equipment sale + recurring software (AMC @ 15–20% of hardware value annually) - **Patents:** 3+ filed and granted, creating IP moat - **Milestone:** Breakeven expected in Q3–Q4 2025 after ₹22–25 crore in prior investment The platform is now in **pilot projects** with two of India’s top five pharmaceutical companies—potential references to accelerate adoption. #### **C. Packaging Division – V-Shapes & Mono-Dose Innovation** Control Print's most ambitious diversification into **high-growth, sustainable packaging** via the acquisition of **V-Shapes SRL**, now **CP Italy**. - **Technology:** - Single-dose (monodose) sachet machines (Alpha Series, Twin Prime) - Precision filling (up to 0.5% accuracy) for viscous and liquid products - Customizable for cosmetics, nutraceuticals (honey, shilajit), pharma (Viagra, Kamagra), and food - **Addressable Market:** Far larger than coding and marking; targets premium segments where customers accept ₹1–2/unit cost - **Co-Packaging Strategy:** - Offers contract filling and small-batch (50k–200k units) market testing from **Nalagarh Unit 2** - Lowers entry barrier for SMEs and startups - "Try before you buy" model to drive machine sales - **Material Innovation:** - Developing **fully recyclable homopolymer** material to address ESG concerns in Europe - Aims to reduce material cost from ₹2 to ₹1/unit via local Indian manufacturing - **Breakeven Path:** Expected after selling 60–70 small machines; currently in investment phase --- ### **4. Strategic Direction (Nov 2025)** Control Print’s strategy is centered on **three-phase growth**: | **Business Type** | **Phase** | **Growth Objective** | |-------------------|--------|------------------------| | **Core Coding & Marking** | Mature | Sustain >18% market share, grow 1.5x GDP, premium value proposition via reliability (99.5% uptime) | | **Track & Trace (QRiousCodes)** | Scaling | Exploit regulatory mandates; achieve breakeven and scale with pharmaceutical references | | **Packaging (V-Shapes)** | Early-Stage | Stabilization; achieve product-market fit and reduce material costs for mass adoption | #### **Growth Drivers:** - **Global Access:** Leveraging subsidiaries to enter Europe and Middle East - **High-Value Customers:** Focusing on large volume clients (top 1,000–2,000 Indian firms) to optimize sales resource utilization - **Direct Sales & Lead Gen:** Dedicated internal team targeting small customers ("last-mile") to increase market penetration - **Consumables Expansion:** Driven by industrial revival and installed base growth --- ### **5. Competitive Advantages** - **Indian Advantage:** Only “Make in India” player with in-house design, manufacturing, R&D, and service - **IP & Patents:** Proprietary tech in T&T and packaging; RFID locks for ink/consumables (like Tetra Pak model) - **End-to-End Integration:** Full-stack provider—hardware, software, vision, automation, ERP integration. Competitors often fragmented. - **Strong After-Sales:** Industry-best service network ensures customer stickiness and low churn - **Technology Adaptation:** Integrates foreign-acquired tech (Markprint, Codeology) into India-ready, cost-optimized products --- ### **6. Capital & Operational Efficiency** - **Manufacturing:** - **Nalagarh (30,000 sq. ft):** CIJ, LCP, TTO, repair, training - **Guwahati (70,000 sq. ft):** Inks, solvents, TIJ, HiRes printers - Planning a **100,000 sq. ft** new facility - **Localization:** Reducing import dependency by manufacturing printing materials and recyclable films in India - **R&D:** Dedicated in-house teams for coding, T&T, and packaging innovation - **ERP System:** Fully integrated SAP-based platform for operational transparency and efficiency - **Cash Position:** Strong liquidity; no immediate capex need, depreciation covers core business investment --- ### **7. Risks & Challenges** | **Risk** | **Mitigation** | |--------|--------------| | **Customer Stickiness (in T&T)** | Offering 30–50% more value than ACG, OPTEL, PharmaSecure to justify switching | | **Execution Risk in New Segments** | Phased rollout, pilot projects, and two-year stabilization plan for packaging | | **Global Economic Volatility** | Focused expansion in regions with existing customer demand (MEA, EU) | | **Material Cost & Waste** | Local manufacturing and R&D on recyclable structures underway | | **Long Sales Cycles** | Focusing on key pharma references to build market momentum |